(88 days)
Not Found
No
The 510(k) summary describes mechanical orthopedic implants (screws and subtalar implants) and their intended use and performance testing. There is no mention of software, algorithms, image processing, AI, ML, or any data-driven decision-making components. The performance studies focus on mechanical properties.
Yes
The devices (BRM TOOL Screws and BIOPLAN Subtalar Implants) are used in surgical orthopedic interventions to treat conditions like bone fractures, flat foot, and subtalar instability, aiming to restore normal function and alleviate symptoms. These applications directly align with the definition of a therapeutic device designed to cure, mitigate, treat, or prevent disease.
No
The device description and indications for use clearly state that these are implants and surgical tools used for repairing bone fractures, stabilizing joints, and correcting foot deformities. They are therapeutic devices, not diagnostic ones.
No
The device description clearly states that the devices are physical implants (screws and subtalar implants) made of Titanium alloy and PEEK, which are hardware components. There is no mention of any software component.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening.
- Device Description and Intended Use: The provided text clearly describes the BRM TOOL Screws and BIOPLAN Subtalar Implants as devices intended for surgical implantation to repair bone fractures, stabilize joints, and correct foot deformities. They are used directly on the patient's body during surgery.
- Lack of Specimen Analysis: There is no mention of these devices being used to analyze any biological specimens taken from the patient.
Therefore, based on the provided information, these devices fall under the category of implantable surgical devices, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
BRM TOOL Screws
The BRM TOOL Screws are indicated for use for aligned bone fracture repair and arthrodesis, osteotomy, joint fusion, and bone fragment fixation appropriate with the size of the screw.
The BIOPLAN Implant is indicated for use in the treatment of the hyperpronated foot and stabilization of the subtalar joint. It is designed to block forward, downward and medial displacement of the talus, thus allowing normal subtalar joint motion but blocking excessive pronation and the resulting sequela.
- Flat foot treatment in children and adolescents
- Congenital flat foot
- Non successful long term orthopaedic treatment (shoes, insoles ... )
- Tarsal coalitions
- Painfully flat foot
- Supple deformity in posterior tibial tendon dysfunction
- Paralytic flat foot
- Subtalar instability
Product codes
HWC
Device Description
The BRM TOOL Screws are interfragmentary compression osteosynthesis screws, i.e., devices used in surgical orthopedic interventions to provide support to the bone structure, with the aim to reduce fractures in several parts of the skeleton, particularly of bone epiphyses. The application field excludes spinal, rib cage and skull bones. The BRM TOOL Screws are available in Titanium alloy. The BIOPLAN Subtalar Implants are used for the correction of the flatfoot pathology. The BIOPLAN Subtalar Implants are available in Titanium alloy and PEEK options.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
bones, particularly of bone epiphyses. The application field excludes spinal, rib cage and skull bones; subtalar joint; foot
Indicated Patient Age Range
children and adolescents
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing included static strength and fatigue strength testing, pushout and pull-out testing, as well as insertion and extraction torque testing. Results were determined to meet the pre- defined acceptance criteria per ASTM F543 and ASTM F1264. Additionally, the BRM Screw Family is in compliance with LAL testing requirements for orthopedic devices per AAMI ST-72 testing.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3040 Smooth or threaded metallic bone fixation fastener.
(a)
Identification. A smooth or threaded metallic bone fixation fastener is a device intended to be implanted that consists of a stiff wire segment or rod made of alloys, such as cobalt-chromium-molybdenum and stainless steel, and that may be smooth on the outside, fully or partially threaded, straight or U-shaped; and may be either blunt pointed, sharp pointed, or have a formed, slotted head on the end. It may be used for fixation of bone fractures, for bone reconstructions, as a guide pin for insertion of other implants, or it may be implanted through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
December 16, 2022
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION".
BRM Extremities % Timothy Sutton Associate, Regulatory Affairs Mcra, LLC. 803 7th Street NW, Floor 3 Washington, District of Columbia 20001
Re: K222820
Trade/Device Name: BRM TOOL Screws, BIOPLAN Subtalar Implant Regulation Number: 21 CFR 888.3040 Regulation Name: Smooth or threaded metallic bone fixation fastener Regulatory Class: Class II Product Code: HWC Dated: September 19, 2022 Received: September 19, 2022
Dear Timothy Sutton:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Shumaya Ali-S
Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K222820
Device Name BRM Screw Family
Indications for Use (Describe)
BRM Tool Screws
The BRM TOOL Screws are indicated for use for aligned bone fracture repair and arthrodesis, osteotomy, joint fusion, and bone fragment fixation appropriate with the size of the screw.
The BIOPLAN Implant is indicated for use in the treatment of the hyperpronated foot and stabilization of the subtalar joint. It is designed to block forward, downward and medial displacement of the talus, thus allowing normal subtalar joint motion but blocking excessive pronation and the resulting sequela.
- · Flat foot treatment in children and adolescents
- · Congenital flat foot
- · Non successful long term orthopaedic treatment (shoes, insoles ... )
- · Tarsal coalitions
- Painfully flat foot
- · Supple deformity in posterior tibial tendon dysfunction
- · Paralytic flat foot
- Subtalar instability
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
7. 510(k) Summary
| Manufacturer: | BRM Extremities S.r.l. | |
|---|---|---|
| Registered Office: | Via Lorenzo Mascheroni 29 | |
| 20145 Milano (MI) - Italy | ||
| Headquarter: | Via Papa Giovanni XXIII, 9 | |
| 23862 Civate (LC) – Italy | ||
| Contact: | Lisa Fazzini | |
| Quality and Regulatory Affairs Manager | ||
| BRM Extremities Srl | ||
| Tel. +39 0341 1693087 | ||
| Email. L.fazzini@brm-extremities.com | ||
| Prepared By: | MCRA, LLC | |
| 803 7th Street NW | ||
| Washington, DC 20001 | ||
| Phone: 202.552.5800 | ||
| Date Prepared: | December 14th, 2022 | |
| Device Trade Name: | BRM Screw Family | |
| BRM TOOL Screws | ||
| BIOPLAN Subtalar Implants | ||
| Device Common Name: | Smooth or Threaded Metallic Bone Fixation Fastener | |
| Classification: | 21 CFR 888.3040 – Screw, Fixation, Bone | |
| Class II | ||
| Product Codes: | HWC |
Indications for Use:
BRM TOOL Screws
The BRM TOOL Screws are indicated for use for aligned bone fracture repair and arthrodesis, osteotomy, joint fusion and bone fragment fixation appropriate with the size of the screw.
BIOPLAN Subtalar Implants
The BIOPLAN Subtalar Implant is indicated for use in the treatment of the hyperpronated foot and stabilization of the subtalar joint. It is designed to block forward and medial displacement of the talus, thus allowing normal subtalar joint motion but blocking excessive pronation and the resulting sequela.
- Flat foot treatment in children and adolescents ●
4
- Congenital flat foot
- Non successful long term orthopaedic treatment (shoes, insoles ...) ●
- Tarsal coalitions
- . Painfully flat foot
- Supple deformity in posterior tibial tendon dysfunction
- Paralytic flat foot ●
- Subtalar instabilitv .
Device Description:
The BRM TOOL Screws are interfragmentary compression osteosynthesis screws, i.e., devices used in surgical orthopedic interventions to provide support to the bone structure, with the aim to reduce fractures in several parts of the skeleton, particularly of bone epiphyses. The application field excludes spinal, rib cage and skull bones. The BRM TOOL Screws are available in Titanium alloy. The BIOPLAN Subtalar Implants are used for the correction of the flatfoot pathology. The BIOPLAN Subtalar Implants are available in Titanium alloy and PEEK options.
Predicate Devices and Technological Comparison:
The BRM Screw Family of devices are substantially equivalent to the primary predicate BRM TOOL Screws (K203773) and additional predicate In2Bone PIT'Stop Subtalar Implant (K170688) with respect to intended use, indications for use, design and materials (Titanium Alloy and PEEK).
Performance Testing:
Testing included static strength and fatigue strength testing, pushout and pull-out testing, as well as insertion and extraction torque testing. Results were determined to meet the pre- defined acceptance criteria per ASTM F543 and ASTM F1264. Additionally, the BRM Screw Family is in compliance with LAL testing requirements for orthopedic devices per AAMI ST-72 testing.
Substantial Equivalence Conclusion:
The BRM Screw Family and the legally marketed predicate devices have the same intended use and indications for use, similar dimensions, geometry and materials. Additionally, information presented in the Mechanical Testing section demonstrate that the screws met the pre-defined acceptance criteria per ASTM F543 and ASTMF1264.